Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
82 /100
CRITICAL RISK
Score updated Aug 28, 2026

SXTP — 60 Degrees Pharmaceuticals, Inc. Dilution Risk Tracker

Track SXTP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SXTP — Get alerts when the score changes →

As of August 28, 2026, 60 Degrees Pharmaceuticals, Inc. (SXTP) has a DilutionWatch DilutionScore of 82/100, rated CRITICAL dilution risk. 60 Degrees Pharmaceuticals, Inc. has a market capitalization of $3.96M, 3.52M shares outstanding, 7 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $565.0K, 10.9K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 37% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 53%
• Low cash runway: 5 months remaining
• Active ATM program with $1M remaining capacity
🔄 Reverse Split model est. 45%
• 50-day avg $1.65 approaching $1 threshold
• Only 5 months cash — financial pressure
🔔 Track SXTP — Get forecast alerts →

Market Data

Market Cap$3.96M
Shares Outstanding3.52M
Float2.44M
Cash$2.26M
Debt$3.14M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 4.0% shares (2025Q4 vs prior)
7 institutional holders · 44.4K shares
#1 JANE STREET GROUP, LLC 22.1K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 12.4K shares
#3 Tower Research Capital LLC (TRC) 6.7K shares
+ 4 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest205.6K
Days to Cover1.5
% of Float8.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2023-12-31
424B5 ATM 2026-03-13
424B5 ATM 2026-03-11
424B5 ATM 2026-03-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SXTP Dilution Snapshot

60 Degrees Pharmaceuticals, Inc. (SXTP) has a DilutionScore of 82/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SXTP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SXTP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SXTP
SXTP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.